| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
ETHZilla Corporation
13G/A
Amendment 2
FRMM · 68236V401
|
0% |
2/17/2026
Event 12/31/2025
|
|||
| FF Consumer Growth II, LP | 0% | ||||
| The Founders Fund Growth II Management, LP | 0% | ||||
| FF Upper Tier GP, LLC | 0% | ||||
| FF Consumer Growth, LLC | 0% | ||||
| The Founders Fund Growth Management, LLC | 0% | ||||
| Peter Thiel | 0% | ||||
|
ETHZilla Corporation
13G/A
Amendment 1
FRMM · 68236V401
|
5.6% |
11/14/2025
Event 9/30/2025
|
|||
| FF Consumer Growth II, LP | 4.4% | ||||
| The Founders Fund Growth II Management, LP | 4.4% | ||||
| FF Upper Tier GP, LLC | 4.4% | ||||
| FF Consumer Growth, LLC | 1.3% | ||||
| The Founders Fund Growth Management, LLC | 1.3% | ||||
| Peter Thiel | 5.6% | ||||
|
Bitmine Immersion Technologies, Inc.
13G/A
Amendment 1
BMNR · 09175A206
|
0.9% |
11/14/2025
Event 9/30/2025
|
|||
| FF Consumer Growth II, LP | 0.7% | ||||
| The Founders Fund Growth II Management, LP | 0.7% | ||||
| FF Upper Tier GP, LLC | 0.7% | ||||
| FF Consumer Growth, LLC | 0.2% | ||||
| The Founders Fund Growth Management, LLC | 0.2% | ||||
| Peter Thiel | 0.9% | ||||
|
180 Life Sciences Corp.
13G
ETHZ · 68236V302
|
7.5% |
8/11/2025
Event 8/4/2025
|
|||
| FF Consumer Growth II, LP | 5.8% | ||||
| The Founders Fund Growth II Management, LP | 5.8% | ||||
| FF Upper Tier GP, LLC | 5.8% | ||||
| FF Consumer Growth, LLC | 1.7% | ||||
| The Founders Fund Growth Management, LLC | 1.7% | ||||
| Peter Thiel | 7.5% | ||||
|
Bitmine Immersion Technologies, Inc.
13G
BMNR · 09175A206
|
9.1% |
7/15/2025
Event 7/8/2025
|
|||
| FF Consumer Growth II, LP | 7.0% | ||||
| The Founders Fund Growth II Management, LP | 7.0% | ||||
| FF Upper Tier GP, LLC | 7.0% | ||||
| FF Consumer Growth, LLC | 2.1% | ||||
| The Founders Fund Growth Management, LLC | 2.1% | ||||
| Peter Thiel | 9.1% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.